TrialCancer immunology, immunotherapy : CII2012

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.

Neil L Berinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.